Education
About Us
Working with TipRanks
Follow Us
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
RESEARCH TOOLSreports
ARTV Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARTV Stock 12 Month Forecast
Average Price Target
$17.00
▲(975.95%Upside)
| Highest Price Target$20.00 | Average Price Target$17.00 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$1.5
Sell
-5.06%
Downside
Reiterated
06/19/25
Artiva Biotherapeutics, Inc.'s overall score is primarily impacted by financial performance challenges, including negative profit margins and cash flow difficulties. The technical analysis indicates weak momentum, while the valuation reflects significant losses and lack of dividends. Without recent earnings call data, the focus remains on these financial and technical factors.
H.C. Wainwright
$12
Buy
659.49%
Upside
Initiated
06/11/25
TD Cowen
―
Buy
―
Reiterated
05/14/25
Needham
$23→$18
Buy
1039.24%
Upside
Reiterated
05/14/25
Unknown AnalystWedbush
Not Ranked
Wedbush
$18
Buy
1039.24%
Upside
Reiterated
05/14/25
Cantor Fitzgerald
$20
Buy
1165.82%
Upside
Reiterated
03/25/25
Jefferies
$21
Buy
1229.11%
Upside
Initiated
08/13/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$1.5
Sell
-5.06%
Downside
Reiterated
06/19/25
Artiva Biotherapeutics, Inc.'s overall score is primarily impacted by financial performance challenges, including negative profit margins and cash flow difficulties. The technical analysis indicates weak momentum, while the valuation reflects significant losses and lack of dividends. Without recent earnings call data, the focus remains on these financial and technical factors.
H.C. Wainwright
$12
Buy
659.49%
Upside
Initiated
06/11/25
TD Cowen
―
Buy
―
Reiterated
05/14/25
Needham
$23→$18
Buy
1039.24%
Upside
Reiterated
05/14/25
Unknown AnalystWedbush
Not Ranked
Wedbush
$18
Buy
1039.24%
Upside
Reiterated
05/14/25
Cantor Fitzgerald
$20
Buy
1165.82%
Upside
Reiterated
03/25/25
Jefferies
$21
Buy
1229.11%
Upside
Initiated
08/13/24
Best Analysts Covering Artiva Biotherapeutics, Inc.
1 Month
xxx
Success Rate
1/5 ratings generated profit
Average Return
-4.26%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -4.26% per trade.
3 Months
xxx
Success Rate
2/5 ratings generated profit
Average Return
-26.76%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -26.76% per trade.
1 Year
2 Years
xxx
Success Rate
0/5 ratings generated profit
Average Return
-55.56%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -55.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARTV Analyst Recommendation Trends
Rating
Dec 24
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
2
6
6
9
6
Buy
2
2
1
3
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
8
7
12
8
Each month's total comprises the sum of three months' worth of ratings.
ARTV Financial Forecast
ARTV Stock Forecast FAQ
What is ARTV’s average 12-month price target, according to analysts?
Based on analyst ratings, Artiva Biotherapeutics, Inc.’s 12-month average price target is 17.00.
What is ARTV’s upside potential, based on the analysts’ average price target?
Artiva Biotherapeutics, Inc. has 975.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARTV a Buy, Sell or Hold?
Artiva Biotherapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Artiva Biotherapeutics, Inc.’s price target?
The average price target for Artiva Biotherapeutics, Inc. is 17.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $12.00. The average price target represents 975.95% Increase from the current price of $1.58.
The highest analyst price target is $20.00 ,the lowest forecast is $12.00. The average price target represents 975.95% Increase from the current price of $1.58.
What do analysts say about Artiva Biotherapeutics, Inc.?
Artiva Biotherapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of ARTV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.